Considerations for pharmacologic management of rheumatoid arthritis in the COVID-19 era: a narrative review
R Venkat, ZS Wallace, JA Sparks - Current Rheumatology Reports, 2023 - Springer
Abstract Purpose of Review To review the impact of disease-modifying antirheumatic drugs
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
A Zaccardelli, ZS Wallace… - Current opinion in …, 2023 - journals.lww.com
Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysis
Background Although patients with rheumatic and musculoskeletal diseases (RMDs) are at
increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they …
increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they …
[HTML][HTML] Comorbidities in the COVID-19 pandemic: scopus-based bibliometric analysis
Y Fedorchenko, O Zimba - Journal of Korean Medical …, 2023 - synapse.koreamed.org
Background Comorbidities attract enormous attention amid the coronavirus disease 2019
(COVID-19) pandemic. Mapping knowledge based on these clinical conditions is …
(COVID-19) pandemic. Mapping knowledge based on these clinical conditions is …
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019
SE Sattui, ZS Wallace - Rheumatic Disease Clinics, 2023 - rheumatic.theclinics.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has represented a major challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has represented a major challenge to …
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease …
L Palazzo, J Lindblom, E Kihlgren Olsson… - Rheumatology …, 2024 - Springer
Objective To determine the occurrence of breakthrough COVID-19 infections (BIs) in patients
with systemic lupus erythematosus (SLE) compared with patients with other rheumatic …
with systemic lupus erythematosus (SLE) compared with patients with other rheumatic …
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
This study aimed to assess the incidence, predictors, and outcomes of breakthrough
infection (BI) following coronavirus disease (COVID-19) vaccination in patients with systemic …
infection (BI) following coronavirus disease (COVID-19) vaccination in patients with systemic …
Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality
Objectives Investigate whether individuals with inflammatory arthritis (IA), their treatments
and shielding status affect the risk of adverse outcomes from COVID-19 for the entire …
and shielding status affect the risk of adverse outcomes from COVID-19 for the entire …
[HTML][HTML] Impact of COVID-19 on Disease Self-management Among Patients With Advanced CKD: A Qualitative Study
Rationale & Objective Patients with advanced chronic kidney disease (CKD) and their care
partners experienced decreased access to care, and worse physical and emotional health …
partners experienced decreased access to care, and worse physical and emotional health …
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A …
E De Lorenzis, P Parente, G Natalello… - Joint bone …, 2022 - pmc.ncbi.nlm.nih.gov
Since the COVID-19 outbreak, public health authorities have looked for the best evidence on
infection risk and prognosis to guide their choices. The interpretation of the observational …
infection risk and prognosis to guide their choices. The interpretation of the observational …